turoctocog alfa pegol

The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).

Form: powder and solvent for injection solution

ATC: B02BD02

Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).

Form: powder and solvent for injection solution

ATC: B02BD02

Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).

Form: powder and solvent for injection solution

ATC: B02BD02

Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).

Form: powder and solvent for injection solution

ATC: B02BD02

Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)

The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).

Form: powder and solvent for injection solution

ATC: B02BD02

Manufacturer: A/S Novo Nordisk (responsible for batch release of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product, addition of scale to injection pen, labeling and secondary packaging of finished medicinal product; preparation, filling into primary packaging, lyophilization and inspection of finished medicinal product, quality control (microbiological tests) of finished medicinal product)